Press Releases

Pfizer Inc and Astellas Pharma Inc announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC). In 2019, it is estimated that...

Novartis will work with Amazon Web Services (AWS) to increase efficiencies across its manufacturing, supply chain and delivery operations. The company will use AWS’ portfolio of cloud services to create custom solutions which use artificial intelligence and machine learning...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products announced that it has completed clinical production of Bridge Therapeutics Inc.’s (Bridge) opioid addiction development therapeutic product,...

Stirling, UK – Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%. In the last 12 months Symbiosis has invested over £1.5m ($1.9m) in...

Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that it will be a leading exhibitor at Pharmapack 2020, which will take place February 5-6 at Paris Expo, Porte de Versailles, in Paris, France. Located...

Following the completed renovation of the TNT Life Science Center in Tokyo, Japan in May 2019, FedEx Express is bolstering its healthcare solutions to support and better meet the complex logistics needs of its pharmaceutical customers in Asia Pacific....

Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis. The research collaboration will focus on discovering and developing HSD17B (17-beta-hydroxysteroid dehydregonase) inhibitors, which is a family of enzymes that regulates hormone action in specific...